- Home
- / Ra Pharmaceuticals
Ra Pharmaceuticals
Revenue
$3 M
FY, 2019
Ra Pharmaceuticals Summary
Company Summary
- Overview
- Ra Pharma® is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2008
- HQ
- Cambridge, MA, US | view all locations
- Website
- http://rapharma.com/
- Cybersecurity rating
- Sectors
Table of Contents
Key People
Peter Diroma, Senior Vice President, Regulatory, Quality, and Government Affairs
Joe Shulman, Senior Vice President, Technical Operations
Doug Treco, President and CEO
LocationsView all
1 location detected
Cambridge, MA HQ
United States
87 Cambridgepark Dr
Ra Pharmaceuticals Financials
Summary Financials
- Revenue (FY, 2019)
- $3.0M
- Net income (FY, 2019)
- ($102.7M)
- Cash (FY, 2019)
- $265.0M
- EBIT (FY, 2019)
- ($107.0M)